A detailed history of Israel Englander (Millennium Management LLC) transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Millennium Management LLC holds 347,056 shares of AMRN stock, worth $204,763. This represents 0.0% of its overall portfolio holdings.

Number of Shares
347,056
Previous 1,544,829 77.53%
Holding current value
$204,763
Previous $1.37 Million 82.61%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.63 - $1.07 $754,596 - $1.28 Million
-1,197,773 Reduced 77.53%
347,056 $239,000
Q1 2024

May 15, 2024

SELL
$0.82 - $1.35 $814,888 - $1.34 Million
-993,767 Reduced 39.15%
1,544,829 $1.37 Million
Q4 2023

Feb 14, 2024

BUY
$0.66 - $0.91 $50,761 - $69,989
76,912 Added 3.12%
2,538,596 $2.21 Million
Q2 2023

Aug 14, 2023

SELL
$1.12 - $1.49 $3.77 Million - $5.01 Million
-3,362,066 Reduced 57.73%
2,461,684 $2.93 Million
Q1 2023

May 15, 2023

SELL
$1.19 - $2.19 $1.31 Million - $2.41 Million
-1,100,051 Reduced 15.89%
5,823,750 $8.74 Million
Q4 2022

Feb 14, 2023

BUY
$1.07 - $1.34 $5.52 Million - $6.91 Million
5,158,279 Added 292.17%
6,923,801 $8.38 Million
Q3 2022

Nov 14, 2022

SELL
$1.09 - $1.67 $851,603 - $1.3 Million
-781,288 Reduced 30.68%
1,765,522 $1.92 Million
Q2 2022

Aug 15, 2022

SELL
$1.13 - $3.69 $2.64 Million - $8.63 Million
-2,338,574 Reduced 47.87%
2,546,810 $3.8 Million
Q1 2022

May 16, 2022

BUY
$2.85 - $3.73 $4.32 Million - $5.65 Million
1,515,872 Added 44.99%
4,885,384 $16.1 Million
Q4 2021

Feb 14, 2022

BUY
$3.24 - $5.18 $6.58 Million - $10.5 Million
2,030,046 Added 151.56%
3,369,512 $11.4 Million
Q3 2021

Nov 15, 2021

SELL
$3.94 - $5.84 $2.45 Million - $3.63 Million
-620,909 Reduced 31.67%
1,339,466 $6.83 Million
Q2 2021

Aug 16, 2021

SELL
$4.26 - $6.5 $4.78 Million - $7.29 Million
-1,121,473 Reduced 36.39%
1,960,375 $8.59 Million
Q1 2021

May 17, 2021

SELL
$5.03 - $8.8 $2.66 Million - $4.65 Million
-528,288 Reduced 14.63%
3,081,848 $19.1 Million
Q4 2020

Feb 16, 2021

BUY
$4.04 - $5.31 $6.79 Million - $8.93 Million
1,681,450 Added 87.18%
3,610,136 $17.7 Million
Q3 2020

Nov 16, 2020

SELL
$3.64 - $7.76 $9.28 Million - $19.8 Million
-2,550,374 Reduced 56.94%
1,928,686 $8.12 Million
Q2 2020

Aug 14, 2020

BUY
$4.78 - $8.26 $9.64 Million - $16.7 Million
2,016,805 Added 81.91%
4,479,060 $31 Million
Q1 2020

May 14, 2020

BUY
$4.0 - $21.53 $3.69 Million - $19.9 Million
923,731 Added 60.04%
2,462,255 $9.85 Million
Q4 2019

Feb 14, 2020

SELL
$13.94 - $24.12 $42.2 Million - $73 Million
-3,026,124 Reduced 66.29%
1,538,524 $33 Million
Q3 2019

Nov 14, 2019

BUY
$13.89 - $23.16 $24.3 Million - $40.5 Million
1,749,742 Added 62.16%
4,564,648 $69.2 Million
Q2 2019

Aug 15, 2019

BUY
$16.27 - $20.51 $44 Million - $55.4 Million
2,703,280 Added 2421.73%
2,814,906 $54.6 Million
Q2 2019

Aug 14, 2019

SELL
$16.27 - $20.51 $49.7 Million - $62.7 Million
-3,055,811 Reduced 96.48%
111,626 $19.3 Million
Q1 2019

May 14, 2019

SELL
$12.61 - $22.33 $31 Million - $54.9 Million
-2,456,894 Reduced 43.68%
3,167,437 $65.8 Million
Q4 2018

Feb 14, 2019

BUY
$12.41 - $22.98 $43.6 Million - $80.7 Million
3,511,705 Added 166.22%
5,624,331 $76.5 Million
Q3 2018

Nov 14, 2018

SELL
$2.45 - $16.27 $4.55 Million - $30.2 Million
-1,855,351 Reduced 46.76%
2,112,626 $34.4 Million
Q2 2018

Aug 14, 2018

SELL
$2.68 - $3.48 $2.43 Million - $3.16 Million
-907,180 Reduced 18.61%
3,967,977 $12.3 Million
Q1 2018

May 15, 2018

BUY
$2.99 - $4.44 $5.02 Million - $7.46 Million
1,680,136 Added 52.59%
4,875,157 $14.7 Million
Q4 2017

Feb 14, 2018

SELL
$3.06 - $4.09 $849,119 - $1.13 Million
-277,490 Reduced 7.99%
3,195,021 $12.8 Million
Q3 2017

Nov 14, 2017

BUY
$3.03 - $3.72 $10.5 Million - $12.9 Million
3,472,511
3,472,511 $12.2 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $238M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.